Venlafaxine in the treatment of panic disorder

Venlafaxine XR is a novel, dual acting SNRI antidepressant, which inhibits both serotonin and norepinephrine reuptake. Controlled trials have demonstrated the efficacy and safety of venlafaxine in the treatment of panic disorder. Generally well tolerated, with side-effects that usually abate with co...

Descripción completa

Detalles Bibliográficos
Autores principales: Katzman, Martin A, Jacobs, Leslie
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654536/
https://www.ncbi.nlm.nih.gov/pubmed/19300538
_version_ 1782165383135887360
author Katzman, Martin A
Jacobs, Leslie
author_facet Katzman, Martin A
Jacobs, Leslie
author_sort Katzman, Martin A
collection PubMed
description Venlafaxine XR is a novel, dual acting SNRI antidepressant, which inhibits both serotonin and norepinephrine reuptake. Controlled trials have demonstrated the efficacy and safety of venlafaxine in the treatment of panic disorder. Generally well tolerated, with side-effects that usually abate with continued treatment, venlafaxine is an important option to the SSRIs for the treatment of patients with panic disorder.
format Text
id pubmed-2654536
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-26545362009-03-19 Venlafaxine in the treatment of panic disorder Katzman, Martin A Jacobs, Leslie Neuropsychiatr Dis Treat Expert Opinion Venlafaxine XR is a novel, dual acting SNRI antidepressant, which inhibits both serotonin and norepinephrine reuptake. Controlled trials have demonstrated the efficacy and safety of venlafaxine in the treatment of panic disorder. Generally well tolerated, with side-effects that usually abate with continued treatment, venlafaxine is an important option to the SSRIs for the treatment of patients with panic disorder. Dove Medical Press 2007-02 /pmc/articles/PMC2654536/ /pubmed/19300538 Text en © 2007 Dove Medical Press Limited. All rights reserved
spellingShingle Expert Opinion
Katzman, Martin A
Jacobs, Leslie
Venlafaxine in the treatment of panic disorder
title Venlafaxine in the treatment of panic disorder
title_full Venlafaxine in the treatment of panic disorder
title_fullStr Venlafaxine in the treatment of panic disorder
title_full_unstemmed Venlafaxine in the treatment of panic disorder
title_short Venlafaxine in the treatment of panic disorder
title_sort venlafaxine in the treatment of panic disorder
topic Expert Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654536/
https://www.ncbi.nlm.nih.gov/pubmed/19300538
work_keys_str_mv AT katzmanmartina venlafaxineinthetreatmentofpanicdisorder
AT jacobsleslie venlafaxineinthetreatmentofpanicdisorder

Ejemplares similares